alexa EZH2 and Sonic Hedgehog Inhibition Reduce Proliferation, Migration, In Vitro Tumorigenesis, and CD133 Expression in Desmoplastic Medulloblastoma Cells| Abstract

Journal of Tumour Research & Reports

  • Research Article   
  • J of Tumor Res & Reports,

EZH2 and Sonic Hedgehog Inhibition Reduce Proliferation, Migration, In Vitro Tumorigenesis, and CD133 Expression in Desmoplastic Medulloblastoma Cells

Javier De La Rosa1, Leire Tapia1, Mehdi H Shahi2, Bárbara Meléndez3, Juan A Rey4, Miguel A Idoate5 and Javier S Castresana1*
1Department of Biochemistry and Genetics, University of Navarra School of Sciences, Spain
2Faculty of Medicine, Interdisciplinary Brain Research Centre, Aligarh Muslim University, India
3Molecular Pathology Research Unit, Virgen de la Salud Hospital, Spain
4IdiPaz Research Unit, La Paz University Hospital, Spain
5Department of Pathology, University of Navarra Clinic, Spain
*Corresponding Author : Javier S Castresana, Department of Biochemistry and Genetics, University of Navarra School of Sciences, Pamplona, Spain, Tel: +34948806486, Email: [email protected]

Received Date: Jun 01, 2017 / Accepted Date: Jun 09, 2017 / Published Date: Jun 16, 2017

Abstract

Medulloblastoma is the malignant brain tumor that most affects children and young people. Its treatment is very aggressive and can leave important neurocognitive sequelae in patients. Medulloblastoma can be classified histologically and molecularly in different subtypes. Our work focuses on the specific subtype in which the sonic hedgehog pathway is altered. DAOY cells, which correspond to desmoplastic Shh medulloblastoma, were independently treated with two pharmacological inhibitors: cyclopamine and DZNep. Cyclopamine directly inhibits Smo, thus inhibiting the sonic hedgehog pathway; while DZNep acts at the epigenetic level by inhibiting EZH2 function, a histone-lysine N-methyltransferase. The two inhibitions were compared cellularly and molecularly, demonstrating that both drugs reduced cell viability, colony formation, cell migration and the expression of cancer stem cells related genes, like CD133. In addition, the expression of different genes of the sonic hedgehog, EZH2, and other genes regulated by EZH2 and GLI1 were evaluated. The initial hypothesis, according to which the expression of EZH2 would regulate the sonic hedgehog pathway was not demonstrated. Quite the opposite, we observed that the sonic hedgehog pathway could positively regulate EZH2 expression. Our results, however, should be subjected to further experiments in order to elucidate the relationship between the epigenetic regulation exerted by EZH2 and the regulation of the sonic hedgehog pathway in medulloblastoma.

Keywords: Medulloblastoma; Sonic hedgehog; Cyclopamine; EZH2; DZNep

Citation: Rosa JDL, Tapia L, Shahi MH, Meléndez B, Rey JA, et al. (2017) EZH2 and Sonic Hedgehog Inhibition Reduce Proliferation, Migration, In Vitro Tumorigenesis, and CD133 Expression in Desmoplastic Medulloblastoma Cells. J Brain Tumors Neurooncol 2: 113.

Copyright: ©2017 Rosa JDL, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment
Share This Article
Relevant Topics
Article Usage
  • Total views: 532
  • [From(publication date): 0-2017 - Jul 18, 2018]
  • Breakdown by view type
  • HTML page views: 490
  • PDF downloads: 42
Leave Your Message 24x7